About this policy
The comment period for the MolDX: Erythrocyte Molecular Antigen Typing D L38249 Local Coverage Determination (LCD) began on 10/30/19 and ended on 12/4/19. The notice period for L38249 begins on 9/17/20 and will become effective on 11/1/20. The title of the LCD was revised from MolDX: Erythrocyte Molecular Antigen Typing to MolDX: Blood Product Molecular Antigen Typing. The comments below were received from the provider community.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.